Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Viridian Therapeutics, Inc. VRDN

Full chart Compare
Set alert

Price alert · VRDN

All alert types
31.25 USD +0.39 (+1.26%)

At closeNov 11, 2026, 4:01 PM EST

30.55 -0.70 -2.24%

After hours · Nov 11, 4:01 PM ET

30.32 Day range 31.63
13.18 52-week range 34.29
YTD
+0.42%
1 year
+9.92%

Financial health

Altman Z-Score

2.05 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -9.4×
FY 2016: -4.3×FY 2017: -7.6×FY 2018: -2.7×FY 2019: -0.4×FY 2020: -0.5×FY 2021: -3.0×FY 2022: -7.5×FY 2023: -4.1×FY 2024: -4.8×FY 2025: -9.4×
FY 2016 5y median -4.8× FY 2025
P/S 37.2×
FY 2016: 16.2×FY 2017: 50.1×FY 2018: 10.7×FY 2019: 3.4×FY 2020: 55.7×FY 2021: 79.5×FY 2022: 529×FY 2023: 3104×FY 2024: 4309×FY 2025: 37.2×
FY 2016 5y median 529× FY 2025
P/B 3.7×
FY 2016: -166×FY 2017: 5.2×FY 2018: 1.7×FY 2019: 1.0×FY 2020: 0.5×FY 2021: 1.3×FY 2022: 2.4×FY 2023: 2.2×FY 2024: 1.9×FY 2025: 3.7×
FY 2016 5y median 2.2× FY 2025
P/FCF -9.5×
FY 2016: -7.5×FY 2017: -7.1×FY 2018: -3.3×FY 2019: -0.4×FY 2020: -2.0×FY 2021: -4.3×FY 2022: -9.9×FY 2023: -5.3×FY 2024: -5.6×FY 2025: -9.5×
FY 2016 5y median -5.6× FY 2025
EV/EBITDA -7.3×
FY 2016: -4.2×FY 2017: -6.3×FY 2018: -2.1×FY 2019: 0.0×FY 2020: -0.3×FY 2021: -2.5×FY 2022: -6.1×FY 2023: -3.8×FY 2024: -4.6×FY 2025: -7.3×
FY 2016 5y median -4.6× FY 2025
EV/Sales 35.0×
FY 2016: 15.6×FY 2017: 40.8×FY 2018: 8.0×FY 2019: -0.3×FY 2020: 12.4×FY 2021: 65.6×FY 2022: 444×FY 2023: 2844×FY 2024: 4049×FY 2025: 35.0×
FY 2016 5y median 444× FY 2025
FCF Yield -10.5%
FY 2016: -13.3%FY 2017: -14.2%FY 2018: -30.4%FY 2019: -240.3%FY 2020: -51.0%FY 2021: -23.3%FY 2022: -10.1%FY 2023: -19.0%FY 2024: -17.9%FY 2025: -10.5%
FY 2016 5y median -17.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 23.6%FY 2017: -390.2%FY 2018: -262.8%FY 2019: 100.0%FY 2020: -2595.6%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -512.9%
FY 2016: -374.8%FY 2017: -662.8%FY 2018: -394.5%FY 2019: -941.0%FY 2020: -10512.4%FY 2021: -2690.8%FY 2022: -7579.2%FY 2023: -81035.0%FY 2024: -99018.2%FY 2025: -512.9%
FY 2016 5y median -7579.2% FY 2025
Net Margin -483.6%
FY 2016: -379.8%FY 2017: -662.3%FY 2018: -390.0%FY 2019: -938.6%FY 2020: -10544.3%FY 2021: -2680.2%FY 2022: -7329.2%FY 2023: -75711.5%FY 2024: -89387.1%FY 2025: -483.6%
FY 2016 5y median -7329.2% FY 2025
ROE -47.4%
FY 2016: 3887.7%FY 2017: -68.8%FY 2018: -63.7%FY 2019: -265.8%FY 2020: -92.2%FY 2021: -42.3%FY 2022: -32.9%FY 2023: -53.8%FY 2024: -40.2%FY 2025: -47.4%
FY 2016 5y median -42.3% FY 2025
ROIC -43.8%
FY 2016: -2245.6%FY 2017: -54.6%FY 2018: -53.6%FY 2019: -174.5%FY 2020: -91.2%FY 2021: -41.8%FY 2022: -33.4%FY 2023: -54.8%FY 2024: -43.0%FY 2025: -43.8%
FY 2016 5y median -43.0% FY 2025
ROA -38.1%
FY 2016: -297.6%FY 2017: -50.5%FY 2018: -49.4%FY 2019: -138.4%FY 2020: -84.4%FY 2021: -39.0%FY 2022: -29.8%FY 2023: -48.5%FY 2024: -36.4%FY 2025: -38.1%
FY 2016 5y median -38.1% FY 2025

Growth (YoY)

Revenue 23359.9%
FY 2016: 31.5%FY 2017: 20.0%FY 2018: 109.5%FY 2019: -46.8%FY 2020: -76.5%FY 2021: 182.2%FY 2022: -40.2%FY 2023: -82.3%FY 2024: -3.8%FY 2025: 23359.9%
FY 2016 FY 2025
Operating Income -21.5%
FY 2016: -11.8%FY 2017: -112.1%FY 2018: -24.7%FY 2019: -26.9%FY 2020: -162.9%FY 2021: 27.8%FY 2022: -68.5%FY 2023: -89.5%FY 2024: -17.5%FY 2025: -21.5%
FY 2016 FY 2025
EPS (diluted) 16.6%
FY 2016: 16.3%FY 2017: -17.6%FY 2018: 19.8%FY 2019: -22.6%FY 2020: -53.6%FY 2021: 78.7%FY 2022: 41.3%FY 2023: -35.8%FY 2024: 25.0%FY 2025: 16.6%
FY 2016 FY 2025
Free Cash Flow -18.9%
FY 2016: -3.0%FY 2017: -292.8%FY 2018: 4.0%FY 2019: -32.4%FY 2020: 17.5%FY 2021: -84.2%FY 2022: -72.3%FY 2023: -95.6%FY 2024: -25.8%FY 2025: -18.9%
FY 2016 FY 2025

Financial Health

Current Ratio 12.6×
FY 2016: 0.9×FY 2017: 13.3×FY 2018: 9.7×FY 2019: 2.9×FY 2020: 12.1×FY 2021: 14.7×FY 2022: 12.7×FY 2023: 18.3×FY 2024: 15.4×FY 2025: 12.6×
FY 2016 5y median 14.7× FY 2025
Quick Ratio 12.6×
FY 2016: 0.9×FY 2017: 13.3×FY 2018: 9.7×FY 2019: 2.9×FY 2020: 12.1×FY 2021: 14.7×FY 2022: 12.9×FY 2023: 18.3×FY 2024: 15.4×FY 2025: 12.6×
FY 2016 5y median 14.7× FY 2025
Debt / Equity 0.1×
FY 2016: -3.2×FY 2017: 0.3×FY 2018: 0.2×FY 2019: 0.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 0.2×FY 2017: 1.5×FY 2018: 0.7×FY 2019: 0.4×FY 2020: 1.1×FY 2021: 0.5×FY 2022: 1.2×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -73.4×
FY 2016: -132×FY 2017: -69.3×FY 2018: -37.9×FY 2019: -50.3×FY 2020: -217×FY 2021: -26576×FY 2022: -276×FY 2023: -138×FY 2024: -98.2×FY 2025: -73.4×
FY 2016 5y median -138× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31